Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
Condition(s) studied
Investigational drug(s) / intervention(s)
Usual care: Antihypertensive therapy is adjusted every 3 months on the basis of office blood pressure values.
POST-strategy: Antihypertensive therapy is adjusted every 15 days on the basis of home blood pressure values.
Study summary
The CHARGE-APP project will investigate whether an innovative management strategy of hypertension based on the combination of usual care visits and ESH CARE App compared to standard care, is associated with differences in outcome, including control rate of office, home and ambulatory BP, cardiovascular and renal intermediate end points at one year, and changes in a number of blood pressure-related variables throughout the study.
Eligibility
Primary outcome measure(s)
- Ambulatory Systolic Blood Pressure — 12 months
Change in ambulatory 24h systolic blood pressure
Trial sites (8)
| Facility | City | Region | Status |
|---|---|---|---|
| Private Hospital " Dr Raúl Matera" | Bahía Blanca | Argentina | Recruiting |
| Argerich Hospital | Buenos Aires | Argentina | Recruiting |
| General San Martin Hospital of La Plata | La Plata | Argentina | Recruiting |
| Spanish Hospital of Mendoza | Mendoza | Argentina | Recruiting |
| British Sanatorium of Rosario | Rosario | Argentina | Recruiting |
| Shanghai Institute of Hypertension | Shanghai | Huangpu | Recruiting |
| Jiangsu Province Official Hospital | Jiangse | China | Active Not Recruiting |
| Ruijin Hospital North | Shanghai | China | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03206814 on ClinicalTrials.gov ↗ ← All trials in China